9 Nov 2011 |
| 16:00-17:30 | | Main Meeting Registration |
| 17:30-19:00 | | Sanofi-Aventis Satellite SymposiumSatellite Symposium Programme (pdf)(1.18mb)” |
| 19:00-19:45 | | Welcome Reception |
| 19:45-23:45 | | Speakers Dinner by invitation onlyNovo Nordisk |
10 Nov 2011 |
| 08:50-09:00 | | WelcomeChair(s):Mehul Dattani |
| 09:00-10:30 | | Oral Communications 1 Chair(s):Helen Spoudea & Sabah Alvi |
| 09:00 | OC1.1 | Surgical treatment of children with hyperparathyroidism: single centre experience |
| 09:11 | OC1.2 | Isolation and characterisation of tumorigenic progenitors/stem cells with a stabilizing mutation in beta-catenin, in a mouse model of human adamantinomatous craniopharyngioma. |
| 09:22 | OC1.3 | High likelihood of malignancy in patients presenting with a thyroid nodule |
| 09:33 | OC1.4 | Growth Retardation and Severe Constipation due to the first human, dominant negative Thyroid Hormone Receptor Alpha mutation |
| 09:44 | OC1.5 | DECONVOLUTION ANALYSIS OF 24H SERUM CORTISOL PROFILES INFORMS THE AMOUNT AND DISTRIBUTION OF HYDROCORTSIONE REPLACEMENT THERAPY |
| 09:55 | OC1.6 | Twenty novel mutations in nicotinamide nucleotide transhydrogenase (NNT) causing FGD |
| 10:06 | OC1.7 | Mild GH deficiency due to two novel homozygous mutations in the gene encoding Growth-Hormone Releasing Hormone receptor (GHRHR) in a single family |
| 10:17 | OC1.8 | Mutations in PROKR2 but not PROK2 are associated with congenital hypopituitarism and septo-optic dysplasia |
| 10:30-11:00 | | Coffee |
| 11:00-12:30 | | Symposium 1 – Update on Adrenal DisordersChair(s):John Gregory |
| 11:00 | S16 | Familial Glucocorticoid Deficiency: An UpdateAdrian Clark (Queen Mary University of London, London, UK) |
| 11:30 | S17 | Recent advances in our understanding of adrenal disease and developmentJohn Achermann (London, United Kingdom) |
| 12:00 | S18 | Health problems in Congenital Adrenal Hyperplasia – a UK perspectiveNils Krone (Sheffield, UK) |
| 12:30-14:00 | | Lunch |
| 13:15-14:00 | | Poster Tour |
| 14:00-15:00 | | Oral Communications 2 - Brief Communications Chair(s):Wolfgang Hogler & Caroline Brain |
| 14:00 | OC2.1 | Sperm cryopreservation in adolescent minors with cancer: factors predicting pre-treatment semen quality in 79 minors aged 12-18 years over 10 years |
| 14:06 | OC2.2 | The assessment of bone microarchitecture by high resolution magnetic resonance imaging (micro MRI) in young adults with childhood onset disease |
| 14:12 | OC2.3 | MCM4 mutation causes a novel DNA replication disorder associated with short stature and adrenal failure |
| 14:18 | OC2.4 | Short Term Effects of Recombinant IGF-I therapy in children with Laron’s Syndrome. |
| 14:24 | OC2.5 | A selective effect of IGFBP-3 on brain volumes in healthy children |
| 14:30 | OC2.6 | What defines Vitamin D deficiency biochemically in children? |
| 14:36 | OC2.7 | Selective reduction in trabecular bone mineral density during treatment for childhood acute lymphoblastic leukaemia |
| 14:42 | OC2.8 | Novel SOX2 mutation: from clinical phenotype to identification of new molecular mechanisms of SOX2 action and interactions. |
| 15:00-15:30 | | Tea |
| 15:30-16:30 | | Symposium 2 – Pubertal DisordersChair(s):Mehul Dattani & Liz Crowne |
| 15:30 | S19 | Novel insights into Hypogonadotrophic HypogonadismNelly Pitteloud (Lausanne, Switzerland) |
| 16:00 | S20 | Management of Delayed PubertyLeo Dunkel (London, UK) |
| 16:45-18:00 | | BSPED Annual General Meeting |
| 19:45-20:15 | | Pre-dinner Welcome Reception |
| 20:15-23:45 | | Conference Dinner |
11 Nov 2011 |
| 09:00-10:00 | | Symposium 3 – Novel therapies/management in Diabetes MellitusChair(s):Peter Hindmarsh & James Greening |
| 09:00 | S21 | Insulin resistance syndromesRobert Semple (University of Edinburgh, Edinburgh, UK) |
| 09:30 | S22 | Use of insulin for the early treatment of Type 2 Diabetes MellitusRury Holman () |
| 10:00-10:30 | | BSPED Research Award winners presentation from 2010Session head(s):Tim Cheetham |
| 10:20-10:30 | | BSPED Website LaunchSession head(s):Justin Davies |
| 10:30-11:00 | | Coffee |
| 11:00-11:45 | | Plenary Guest Lecture: Advances in our understanding of the Genetic Causes of ObesitySession head(s):Sadaaf Farooqi |
| 11:45-12:30 | | Oral Communications 3 - Brief CommunicationsChair(s):Tabitha Randell & Rakesh Amin |
| 11:45 | OC3.1 | The impact of growth hormone deficiency (GHD) and growth hormone treatment (GHTx) on the cardiovascular risk in survivors of bone marrow transplantation with total body irradiation (BMT/TBI) in childhood |
| 11:56 | OC3.2 | Clinical, genetic, histological and radiological heterogeneity of focal forms of congenital hyperinsulinism |
| 12:07 | OC3.3 | Laparoscopic near total pancreatectomy for medically unresponsive diffuse congenital hyperinsulinism |
| 12:18 | OC3.4 | The heterogeneity of hyperinsulinaemic hypoglycaemia in 19 patients with Beckwith-Wiedemann syndrome due to KvDMR1 hypomethylation. |
| 12:30-13:30 | | Lunch |
| 13:30-14:15 | | Oral Communications 4 - Brief CommunicationsChair(s):Tabitha Randell & Rakesh Amin |
| 13:30 | OC4.1 | Ethnicity Rather Than Deprivation Impacts on Diabetes Control and use of Treatment Regimen |
| 13:41 | OC4.2 | White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national Type 2 diabetes cohort. |
| 13:52 | OC4.3 | Non-linear Dynamic Analysis of Glucose Regulation in Subjects with Type 2 Diabetes and Controls - Observed Variability and Liability (OVAL) |
| 14:03 | OC4.4 | Natural history of background retinopathy in children and young people with diabetes |
| 14:15-15:55 | | Symposium 4 – Insulin Resistance and Type 2 Diabetes: Novel InsightsChair(s):David Dunger & Jeremy Kirk |
| 14:15 | S24 | Islet cell transplantation: an updatePeter Jones () |
| 14:45 | S25 | Immunology of Type 1 Diabetes MellitusMark Peakman () |
| 15:15 | S26 | Update on closed loop systems for the treatment of Type 1 DMRoman Havorka () |
| 15:55-16:00 | | Close of Meeting |